Global High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3460909
- 99 Pages
- January 2020
- Healthcare
The global High Potency Active Pharmaceutical Ingredients (APIs) market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of High Potency Active Pharmaceutical Ingredients (APIs) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Synthetic
Biotech
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Lonza
Novartis International AG
BASF AG
Carbogen Amcis AG
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb
Pfizer Inc.
Roche Diagnostics.
Hospira Inc
Boehringer Ingelheim
Covidien Plc
Merck & Co
Bayer AG
Sigma-Aldrich Corporation
Sanofi Aventis
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Oncology
Hormonal
Glaucoma
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 High Potency Active Pharmaceutical Ingredients (APIs) Industry
Figure High Potency Active Pharmaceutical Ingredients (APIs) Industry Chain Structure
1.1.1 Overview
1.1.2 Development of High Potency Active Pharmaceutical Ingredients (APIs)
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of High Potency Active Pharmaceutical Ingredients (APIs)
1.2.2 Downstream
Table Application Segment of High Potency Active Pharmaceutical Ingredients (APIs)
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 High Potency Active Pharmaceutical Ingredients (APIs) Market by Type
3.1 By Type
3.1.1 Synthetic
Table Major Company List of Synthetic
3.1.2 Biotech
Table Major Company List of Biotech
3.2 Market Size
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Type, in USD Million
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2015-2019, by Type, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Type, in Volume
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Type, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Lonza (Company Profile, Sales Data etc.)
4.1.1 Lonza Profile
Table Lonza Overview List
4.1.2 Lonza Products & Services
4.1.3 Lonza Business Operation Conditions
Table Business Operation of Lonza (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Novartis International AG (Company Profile, Sales Data etc.)
4.2.1 Novartis International AG Profile
Table Novartis International AG Overview List
4.2.2 Novartis International AG Products & Services
4.2.3 Novartis International AG Business Operation Conditions
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 BASF AG (Company Profile, Sales Data etc.)
4.3.1 BASF AG Profile
Table BASF AG Overview List
4.3.2 BASF AG Products & Services
4.3.3 BASF AG Business Operation Conditions
Table Business Operation of BASF AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Carbogen Amcis AG (Company Profile, Sales Data etc.)
4.4.1 Carbogen Amcis AG Profile
Table Carbogen Amcis AG Overview List
4.4.2 Carbogen Amcis AG Products & Services
4.4.3 Carbogen Amcis AG Business Operation Conditions
Table Business Operation of Carbogen Amcis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Eli Lilly and Company (Company Profile, Sales Data etc.)
4.5.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
4.5.2 Eli Lilly and Company Products & Services
4.5.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.6.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.6.2 Teva Pharmaceutical Industries Ltd Products & Services
4.6.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.7.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.7.2 Bristol-Myers Squibb Products & Services
4.7.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer Inc. (Company Profile, Sales Data etc.)
4.8.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.8.2 Pfizer Inc. Products & Services
4.8.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Roche Diagnostics. (Company Profile, Sales Data etc.)
4.9.1 Roche Diagnostics. Profile
Table Roche Diagnostics. Overview List
4.9.2 Roche Diagnostics. Products & Services
4.9.3 Roche Diagnostics. Business Operation Conditions
Table Business Operation of Roche Diagnostics. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Hospira Inc (Company Profile, Sales Data etc.)
4.10.1 Hospira Inc Profile
Table Hospira Inc Overview List
4.10.2 Hospira Inc Products & Services
4.10.3 Hospira Inc Business Operation Conditions
Table Business Operation of Hospira Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.11.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.11.2 Boehringer Ingelheim Products & Services
4.11.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Covidien Plc (Company Profile, Sales Data etc.)
4.12.1 Covidien Plc Profile
Table Covidien Plc Overview List
4.12.2 Covidien Plc Products & Services
4.12.3 Covidien Plc Business Operation Conditions
Table Business Operation of Covidien Plc (Sales Revenue, Cost, Gross Margin)
4.13 Merck & Co (Company Profile, Sales Data etc.)
4.13.1 Merck & Co Profile
Table Merck & Co Overview List
4.13.2 Merck & Co Products & Services
4.13.3 Merck & Co Business Operation Conditions
Table Business Operation of Merck & Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Bayer AG (Company Profile, Sales Data etc.)
4.14.1 Bayer AG Profile
Table Bayer AG Overview List
4.14.2 Bayer AG Products & Services
4.14.3 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Cost, Gross Margin)
4.15 Sigma-Aldrich Corporation (Company Profile, Sales Data etc.)
4.15.1 Sigma-Aldrich Corporation Profile
Table Sigma-Aldrich Corporation Overview List
4.15.2 Sigma-Aldrich Corporation Products & Services
4.15.3 Sigma-Aldrich Corporation Business Operation Conditions
Table Business Operation of Sigma-Aldrich Corporation (Sales Revenue, Cost, Gross Margin)
4.16 Sanofi Aventis (Company Profile, Sales Data etc.)
4.16.1 Sanofi Aventis Profile
Table Sanofi Aventis Overview List
4.16.2 Sanofi Aventis Products & Services
4.16.3 Sanofi Aventis Business Operation Conditions
Table Business Operation of Sanofi Aventis (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue 2015-2019, by Company, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue Share in 2019, by Company, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume 2015-2019, by Company, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume Share 2015-2019, by Company, in Volume
Figure Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America High Potency Active Pharmaceutical Ingredients (APIs) Market Concentration, in 2019
Figure Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Market Concentration, in 2019
Figure Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) MMarket Concentration, in 2019
Figure South America High Potency Active Pharmaceutical Ingredients (APIs) Market Concentration, in 2019
Figure Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Oncology
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Oncology, 2015-2019, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Oncology, 2015-2019, in Volume
6.1.2 Demand in Hormonal
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Hormonal, 2015-2019, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Hormonal, 2015-2019, in Volume
6.1.3 Demand in Glaucoma
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Glaucoma, 2015-2019, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Glaucoma, 2015-2019, in Volume
6.1.4 Demand in Others
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Others, 2015-2019, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2020-2025, by Application, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2020-2025, by Application, in USD Million
Figure High Potency Active Pharmaceutical Ingredients (APIs) Market Share in 2025, by Application, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2020-2025, by Application, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2020-2025, by Application, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2015-2019, by Region, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Region, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2015-2019, by Region, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Region, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in USD Million
Figure North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in USD Million
Figure Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in USD Million
Figure South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Region, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of High Potency Active Pharmaceutical Ingredients (APIs)
Table Application Segment of High Potency Active Pharmaceutical Ingredients (APIs)
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2025, by Application, in USD Million
Table Major Company List of Biotech
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Type, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Type, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Type, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Type, in Volume
Table Lonza Overview List
Table Business Operation of Lonza (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International AG Overview List
Table Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BASF AG Overview List
Table Business Operation of BASF AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Carbogen Amcis AG Overview List
Table Business Operation of Carbogen Amcis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Diagnostics. Overview List
Table Business Operation of Roche Diagnostics. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hospira Inc Overview List
Table Business Operation of Hospira Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Covidien Plc Overview List
Table Business Operation of Covidien Plc (Sales Revenue, Cost, Gross Margin)
Table Merck & Co Overview List
Table Business Operation of Merck & Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Business Operation of Bayer AG (Sales Revenue, Cost, Gross Margin)
Table Sigma-Aldrich Corporation Overview List
Table Business Operation of Sigma-Aldrich Corporation (Sales Revenue, Cost, Gross Margin)
Table Sanofi Aventis Overview List
Table Business Operation of Sanofi Aventis (Sales Revenue, Cost, Gross Margin)
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue 2015-2019, by Company, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume 2015-2019, by Company, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2020-2025, by Application, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Demand Forecast 2020-2025, by Application, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Growth 2020-2025, by Application, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Share in 2025, by Application, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2015-2019, by Region, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Production 2015-2019, by Region, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Region, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2015-2019, by Region, in USD Million
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market 2015-2019, by Region, in Volume
Table Global High Potency Active Pharmaceutical Ingredients (APIs) Market Share 2015-2019, by Region, in Volume
Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table North America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table Europe High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table South America High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa High Potency Active Pharmaceutical Ingredients (APIs) Market Size 2015-2019, by Country, in Volume
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Region, in USD Million
Table High Potency Active Pharmaceutical Ingredients (APIs) Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
